v3.26.1
Balance Sheet Components
 6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Prepaid and Other Current Assets
Prepaid and other current assets consisted of the following (in thousands):
June 30,
2026		December 31,
2025
Prepaid research and development contract services$699 $115 
Advanced professional fees439 193 
Prepaid insurance624 367 
Other prepaid expenses and other current assets243 73 
Total prepaid and other current assets$2,005 $748 
Property and Equipment, Net
Property and equipment, net was comprised of the following (in thousands):
June 30,
2026		December 31,
2025
Equipment
$1,661 $1,661 
Furniture and fixtures
258 258 
Leasehold improvements
132 132 
Total property and equipment
2,051 2,051 
Less: accumulated depreciation
(1,838)(1,756)
Property and equipment, net
$213 $295 
Depreciation expense for the three and six months ended June 30, 2026 was $0.1 million. For the three and six months ended June 30, 2025, depreciation expense was $0.1 million.
Other Long-term Prepaid Assets
Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.8 million and $0.8 million for June 30, 2026 and December 31, 2025, respectively.
Accrued Expenses
Accrued expenses consisted of the following (in thousands):
June 30,
2026		December 31,
2025
Accrued professional fees$643 $818 
Accrued compensation and benefits1,642 2,528 
Accrued clinical trial and research and development costs
3,547 2,298 
Accrued interest1,430 741 
Other accrued expenses28 42 
Total accrued expenses
$7,290 $6,427